As of 2025-07-04, the Relative Valuation of 89Bio Inc (ETNB) is (35.49) USD. This relative valuation is based on P/E multiples. With the latest stock price at 10.10 USD, the upside of 89Bio Inc based on Relative Valuation is -451.4%.
The range of the Relative Valuation is (27.18) - (49.32) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 8.7x - 18.6x | 13.1x |
| Forward P/E multiples | 10.3x - 21.2x | 13.7x |
| Fair Price | (27.18) - (49.32) | (35.49) |
| Upside | -369.1% - -588.3% | -451.4% |
| Date | P/E |
| 2025-06-27 | -3.72 |
| 2025-06-26 | -3.76 |
| 2025-06-25 | -3.68 |
| 2025-06-24 | -3.71 |
| 2025-06-23 | -3.78 |
| 2025-06-20 | -3.81 |
| 2025-06-18 | -3.78 |
| 2025-06-17 | -3.75 |
| 2025-06-16 | -3.79 |
| 2025-06-13 | -3.93 |
| 2025-06-12 | -3.63 |
| 2025-06-11 | -3.79 |
| 2025-06-10 | -3.88 |
| 2025-06-09 | -3.99 |
| 2025-06-06 | -3.87 |
| 2025-06-05 | -3.76 |
| 2025-06-04 | -3.80 |
| 2025-06-03 | -3.84 |
| 2025-06-02 | -3.82 |
| 2025-05-30 | -3.71 |
| 2025-05-29 | -3.70 |
| 2025-05-28 | -3.48 |
| 2025-05-27 | -3.46 |
| 2025-05-23 | -3.58 |
| 2025-05-22 | -3.64 |
| 2025-05-21 | -3.63 |
| 2025-05-20 | -3.41 |
| 2025-05-19 | -2.91 |
| 2025-05-16 | -2.94 |
| 2025-05-15 | -2.88 |
| 2025-05-14 | -3.10 |
| 2025-05-13 | -2.94 |
| 2025-05-12 | -3.06 |
| 2025-05-09 | -2.91 |
| 2025-05-08 | -2.94 |
| 2025-05-07 | -2.90 |
| 2025-05-06 | -2.93 |
| 2025-05-05 | -3.25 |
| 2025-05-02 | -3.30 |
| 2025-05-01 | -3.07 |
| 2025-04-30 | -3.03 |
| 2025-04-29 | -2.85 |
| 2025-04-28 | -2.79 |
| 2025-04-25 | -2.62 |
| 2025-04-24 | -2.60 |
| 2025-04-23 | -2.50 |
| 2025-04-22 | -2.47 |
| 2025-04-21 | -2.37 |
| 2025-04-17 | -2.29 |
| 2025-04-16 | -2.22 |